Related Experiment Videos
Proteolytic processing of amyloid beta protein precursor (APP) by thrombin.
1Shionogi Institute for Medical Science, Osaka, Japan.
Biochemical and Biophysical Research Communications
|June 30, 1992
Summary
Researchers investigated thrombin
Area of Science:
- Neuroscience
- Biochemistry
- Molecular Biology
Background:
- Alzheimer's disease is characterized by beta-amyloid deposits.
- Amyloid precursor protein (APP) processing typically avoids beta-amyloid generation.
- Identifying proteases altering APP processing is crucial for understanding Alzheimer's disease.
Purpose of the Study:
- To investigate the role of thrombin, a serine protease, in APP processing.
- To determine if thrombin can generate intermediates containing the beta/A4 peptide.
Main Methods:
- In vitro cleavage of mouse recombinant APP695 by thrombin.
- Immunoblot analysis to characterize cleavage fragments.
- Amino acid sequencing to identify cleavage sites.
Main Results:
- Thrombin cleaved recombinant APP695, producing a 28 kDa fragment.
- The 28 kDa fragment originated from the carboxy-terminal side of APP695.
- Cleavage occurred at Arg 510-Ile 511, yielding a fragment containing the entire beta/A4 peptide.
Conclusions:
- The 28 kDa fragment generated by thrombin is a potential intermediate in beta/A4 peptide formation.
- Thrombin may play a role in the altered processing of APP, contributing to Alzheimer's disease pathology.